RecruitingNot ApplicableNCT06744322

Fast Discharge After Acute Myocardial Infarction Discharge MI

Fast Discharge After Acute Myocardial Infarction Discharge MI - A Randomized Multicenter Non Inferiority Trial


Sponsor

Medical University Innsbruck

Enrollment

2,070 participants

Start Date

Dec 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate the hypothesis that a fast discharge strategy (discharge at 24 \[± 12\] hours) following invasive management for acute myocardial infarction is non-inferior to standard of care (\>36 hours) with respect to the risk of major adverse cardiovascular events (MACE) during follow-up.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Fast discharge strategy for people with acute myocardial infarction (ami). The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREFast discharge strategy

Patients undergoing invasive management after myocardial infarction will be discharged after 24 (+/- 12) hours.


Locations(8)

Hospital Wiener Neustadt

Wiener Neustadt, Lower Austria, Austria

Cardinal Schwarzenberg Hospital Schwarzach

Schwarzach im Pongau, Schwarzach Im Pongau, Austria

Paracelsus Medical University Salzburg

Salzburg, State of Salzburg, Austria

Medical University of Graz

Graz, Styria, Austria

Medical University of Innsbruck

Innsbruck, Tyrol, Austria

University Teaching Hospital Wels-Grieskirchen

Wels, Upper Austria, Austria

Academic Teaching Hospital Feldkirch

Feldkirch, Vorarlberg, Austria

Ludwig Maximilian University Munich

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06744322


Related Trials